Firm at a glance
Revelstoke Capital Partners is a platform private equity firm headquartered in Denver, CO, with approximately $6.8 billion in assets under management as of January 2026 [S1].
What they buy
The firm’s portfolio demonstrates a pronounced concentration in healthcare, spanning clinical services, technology infrastructure, and wellness businesses [S2]. Approximately 90% of the publicly disclosed portfolio operates within healthcare subsectors, including specialty physician practices, rehabilitation services, infusion therapy, and health IT platforms [S2]. Outside healthcare, the firm has made at least one investment in transportation and logistics [S2].
Portfolio
Healthcare Services
Accelecare Wound Centers, AOM Infusion, CEI Vision Partners, Claremedica, Connext Global Solutions, Crossroads, Encore Rehabilitation, Family Care Center, Fast Pace Health, Griffin Concierge Medical, Monte Nido, ONsite Mammography, OrthoAlliance, Rarebreed Veterinary Partners, Sound Physicians, The Care Team, TridentUSA Health Services, U.S. Renal Care, Upstream Rehabilitation, and Vet’s Best Friend [S2].
Healthcare Technology
Carrus, DataLink, HealthAxis, MediQuant, Omega Systems, and Vi Labs [S2].
Health & Wellness
Empire Portfolio Group, Evolve Medspa, and NakedMD [S2].
Transportation & Logistics
Transport Investments [S2].
The portfolio also includes one undisclosed healthcare services company [S2].
Recent activity (last 24 months)
* December 4, 2025: Add-on acquisition of Traditions Health by The Care Team [S3]
* September 30, 2025: Acquisition of Griffin Concierge Medical [S3]
* April 15, 2025: Acquisition of AOM Infusion [S3]
* January 16, 2025: Acquisition of Omega Systems [S3]
* November 15, 2024: Acquisition of NAKED MD [S3]
* September 4, 2024: Acquisition of MediQuant [S3]
How this firm fits a seller
Revelstoke appears positioned for healthcare services and technology businesses seeking a buyer with demonstrated sector depth and an active buy-and-build approach. The firm completed six disclosed transactions in the trailing 24 months, indicating ongoing deployment activity [S3]. For owner-operators in specialty healthcare delivery, physician practice management, or health IT, the firm’s portfolio concentration suggests familiarity with regulatory environments and reimbursement models common to these verticals. The presence of multiple rehabilitation, infusion, and specialty care platforms suggests potential add-on opportunities for smaller practices in those subsectors.
Sources
[S1] https://revelstokecapital.com (as of 2026-01-15)
[S2] https://revelstokecapital.com/portfolio/ (as of 2026-01-15)
[S3] https://revelstokecapital.com/news/ (as of 2026-01-15)
Frequently asked questions
Does Revelstoke Capital Partners buy healthcare businesses?
Yes. The firm’s portfolio includes approximately 28 healthcare-related companies across services, technology, and wellness categories, representing the substantial majority of its disclosed investments [S2]. Recent acquisitions include Griffin Concierge Medical, AOM Infusion, and Omega Systems [S3].
What companies has Revelstoke Capital Partners acquired recently?
Recent acquisitions include Griffin Concierge Medical in September 2025, AOM Infusion in April 2025, and Omega Systems in January 2025 [S3]. The firm also completed an add-on transaction involving Traditions Health and The Care Team in December 2025 [S3].
Where is Revelstoke Capital Partners based and how big is the firm?
The firm is based in Denver, CO, and reports approximately $6.8 billion in assets under management as of January 2026 [S1].
Is Revelstoke Capital Partners still actively acquiring?
Yes. The firm completed six disclosed transactions between September 2024 and December 2025, with the most recent activity occurring in December 2025 [S3].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.